Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or OpenAthens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

American Journal of Nephrology

Vol. 46, No. 6, 2017

Issue release date: January 2018

Add all to MyReading List
Original Report: Patient-Oriented, Translational Research

Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients

Kido R. · Akizawa T. · Fukagawa M. · Onishi Y. · Yamaguchi T. · Fukuhara S.
Am J Nephrol 2017;46:439–447 (DOI:10.1159/000482013)
Open Access Gateway

Uremic Pruritus: An Itch with Ominous Consequences

Germain M.J.
Am J Nephrol 2017;46:448–449 (DOI:10.1159/000484572)
Free Access
Novel Research Findings

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus

Mathur V.S. · Kumar J. · Crawford P.W. · Hait H. · Sciascia T. · for the TR02 Study Investigators
Am J Nephrol 2017;46:450–458 (DOI:10.1159/000484573)
Free Access

Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy

Neumiller J.J. · Rhee C.M. · Kalantar-Zadeh K.
Am J Nephrol 2017;46:459–461 (DOI:10.1159/000484669)
Free Access
Original Report: Patient-Oriented, Translational Research

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

Jardine M.J. · Mahaffey K.W. · Neal B. · Agarwal R. · Bakris G.L. · Brenner B.M. · Bull S. · Cannon C.P. · Charytan D.M. · de Zeeuw D. · Edwards R. · Greene T. · Heerspink H.J.L. · Levin A. · Pollock C. · Wheeler D.C. · Xie J. · Zhang H. · Zinman B. · Desai M. · Perkovic V. · on behalf of the CREDENCE study investigators
Am J Nephrol 2017;46:462–472 (DOI:10.1159/000484633)
Open Access Gateway
Novel Research Findings

Combination Cyclophosphamide/Glucocorticoids Provide Better Tolerability and Outcomes versus Glucocorticoids Alone in Patients with Sjogren’s Associated Chronic Interstitial Nephritis

Shen Y. · Xie J. · Lin L. · Li X. · Shen P. · Pan X. · Ren H. · Chen N.
Am J Nephrol 2017;46:473–480 (DOI:10.1159/000484903)
Free Access
Original Report: Patient-Oriented, Translational Research

Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis

Hughes-Austin J.M. · Gan R.W. · Deane K.D. · Weisman M.H. · Demoruelle M.K. · Sokolove J. · Robinson W.H. · Holers V.M. · Norris J.M. · Ix J.H.
Am J Nephrol 2017;46:481–487 (DOI:10.1159/000485259)

Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial

Mc Causland F.R. · Claggett B. · Pfeffer M.A. · Burdmann E.A. · Eckardt K.-U. · Levey A.S. · McMurray J.J.V. · Remuzzi G. · Singh A.K. · Solomon S.D. · Toto R.D. · Parfrey P.
Am J Nephrol 2017;46:488–497 (DOI:10.1159/000485326)
Free Access

Periostin: The Missing Link to Attenuate Kidney Fibrosis

Prakoura N. · Chatziantoniou C.
Am J Nephrol 2017;46:498–500 (DOI:10.1159/000485324)
Free Access
Original Report: Laboratory Investigation

Experimental Inhibition of Periostin Attenuates Kidney Fibrosis

Hwang J.H. · Yang S.H. · Kim Y.C. · Kim J.H. · An J.N. · Moon K.C. · Oh Y.K. · Park J.Y. · Kim D.K. · Kim Y.S. · Lim C.S. · Lee J.P.
Am J Nephrol 2017;46:501–517 (DOI:10.1159/000485325)
Free Access

Contents Vol. 46, 2017

Am J Nephrol 2017;46:519-520 (DOI:10.1159/000481631)
Free Access

Contents Vol. 46, 2017

Am J Nephrol 2017;46:I-VI (DOI:10.1159/000486151)
Free Access